Medicare Enrolled
Dr. Blessy Jacob, M.D.
Hematology · Englewood, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jacob from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jacob? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jacob
Dr. Blessy Jacob is a hematology in Englewood, FL, with 16 years in practice. Based on federal Medicare data, Dr. Jacob performed 298,422 Medicare services across 6,151 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jacob received a total of $13,837 from 81 pharmaceutical and/or device companies across 695 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jacob is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice▲ Top 8% volume in FL$ $13,837 industry payments
Medicare Practice Summary
Medicare Utilization ↗298,422
Medicare services
Top 8% in FL for hematology
6,151
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~18,651 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 108,630 | $0 | $4 |
| Iron infusion (Injectafer) | 42,750 | $1 | $3 |
| Iron sucrose injection (Venofer) | 27,200 | $0 | $5 |
| Nivolumab injection (Opdivo) | 18,220 | $24 | $72 |
| Epoetin alfa injection (Procrit) for anemia | 16,630 | $6 | $23 |
| Pembrolizumab injection (Keytruda) | 14,800 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 12,480 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 11,050 | $1 | $5 |
| Daratumumab injection (Darzalex) | 10,260 | $38 | $110 |
| Immune globulin infusion (Gammagard) | 6,638 | $36 | $108 |
| Paclitaxel chemotherapy injection | 5,796 | $0 | $2 |
| Dexamethasone injection (steroid) | 3,074 | $0 | $3 |
| Blood draw (venipuncture) | 2,947 | $8 | $9 |
| Complete blood count (CBC) with differential | 2,906 | $8 | $29 |
| Injection, eflapegrastim-xnst, 0.1 mg | 2,640 | $26 | $116 |
| Office visit, established patient (30-39 min) | 1,767 | $94 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,450 | $1 | $28 |
| Iron infusion (Monoferric) | 1,300 | $16 | $57 |
| Drug injection, under skin or into muscle | 1,054 | $10 | $69 |
| Injection of additional new drug or substance into vein | 765 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 556 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 460 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 420 | $47 | $189 |
| Injection, leucovorin calcium, per 50 mg | 363 | $3 | $12 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 295 | $16 | $59 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 284 | $1 | $6 |
| Office visit, established patient, complex (40-54 min) | 282 | $136 | $474 |
| Injection, zoledronic acid, 1 mg | 266 | $7 | $69 |
| Injection, carboplatin, 50 mg | 260 | $2 | $41 |
| Injection of drug or substance into vein | 224 | $28 | $156 |
| Injection, fluorouracil, 500 mg | 206 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 197 | $15 | $56 |
| Administration of chemotherapy into vein, each additional hour | 195 | $21 | $79 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 189 | $3 | $11 |
| Infusion into a vein for hydration, each additional hour | 174 | $10 | $42 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 174 | $55 | $206 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 162 | $21 | $84 |
| Injection, diphenhydramine hcl, up to 50 mg | 154 | $1 | $3 |
| Infusion, normal saline solution , 1000 cc | 144 | $2 | $7 |
| New patient office visit (45-59 min) | 136 | $121 | $453 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 135 | $25 | $89 |
| Administration of additional new drug or substance into vein, 1 hour or less | 120 | $49 | $178 |
| Red blood count automated, with additional calculations | 93 | $5 | $20 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 86 | $138 | $562 |
| Infusion into a vein for hydration, 31-60 minutes | 80 | $24 | $156 |
| Automated urinalysis | 59 | $2 | $8 |
| Prothrombin time test (blood clotting) | 55 | $4 | $15 |
| Administration of additional new drug or substance into vein using push technique | 53 | $42 | $170 |
| Hospital follow-up visit, high complexity | 52 | $94 | $285 |
| Office visit, established patient (20-29 min) | 43 | $56 | $239 |
| Drawing of blood for a medical problem | 34 | $62 | $277 |
| Initial hospital admission, high complexity | 34 | $137 | $556 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 30 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 28 | $15 | $56 |
| New patient office visit, complex (60-74 min) | 22 | $166 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
53.8% high complexity
43.2% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,837
Total received (2018-2024)
Avg $1,977/year across 7 years
Top 35% in FL for hematology
81
Companies
695
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,287 (88.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,550 (11.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,564
2023$2,366
2022$1,938
2021$2,030
2020$557
2019$1,885
2018$2,497
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Epizyme, Inc.,
$1,294
E.R. Squibb & Sons, L.L.C.
$1,241
Novartis Pharmaceuticals Corporation
$1,079
AstraZeneca Pharmaceuticals LP
$689
Lilly USA, LLC
$648
Genentech USA, Inc.
$646
Celgene Corporation
$641
Merck Sharp & Dohme Corporation
$583
PFIZER INC.
$542
Janssen Biotech, Inc.
$481
Merck Sharp & Dohme LLC
$480
Gilead Sciences, Inc.
$346
Daiichi Sankyo Inc.
$337
Astellas Pharma US Inc
$320
GENZYME CORPORATION
$315
Incyte Corporation
$279
Exelixis Inc.
$251
Takeda Pharmaceuticals U.S.A., Inc.
$210
Amgen Inc.
$198
Acrotech Biopharma Inc.
$179
Kite Pharma, Inc.
$146
Ipsen Biopharmaceuticals, Inc
$136
ARRAY BIOPHARMA INC
$129
Seagen Inc.
$128
EMD Serono, Inc.
$120
JAZZ PHARMACEUTICALS INC.
$120
Dova Pharmaceuticals
$119
Alexion Pharmaceuticals, Inc.
$110
TerSera Therapeutics LLC
$108
Genmab U.S., Inc.
$107
SANOFI-AVENTIS U.S. LLC
$85
Eisai Inc.
$83
PUMA BIOTECHNOLOGY, INC.
$83
ABBVIE INC.
$82
BeiGene USA, Inc.
$77
GlaxoSmithKline, LLC.
$74
Puma Biotechnology, Inc.
$70
Bayer HealthCare Pharmaceuticals Inc.
$70
AbbVie, Inc.
$64
Pharmacyclics LLC, An AbbVie Company
$63
Dendreon Pharmaceuticals LLC
$58
Bayer Healthcare Pharmaceuticals Inc.
$56
Rigel Pharmaceuticals, Inc.
$56
PharmaEssentia USA Corporation
$54
Sumitomo Pharma America, Inc.
$53
Myovant Sciences Inc.
$50
Epizyme, Inc.
$50
Mirati Therapeutics, Inc.
$42
ImmunoGen, Inc.
$40
SOBI, INC
$38
Regeneron Healthcare Solutions, Inc.
$37
ADC Therapeutics America, Inc.
$34
Partner Therapeutics, Inc.
$34
Array BioPharma Inc.
$30
Stemline Therapeutics Inc.
$29
Coherus Biosciences Inc.
$24
Fennec Pharmaceuticals, Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$23
Lexicon Pharmaceuticals, Inc.
$23
Heron Therapeutics, Inc.
$22
AMAG Pharmaceuticals, Inc.
$22
SERVIER PHARMACEUTICALS LLC
$21
EISAI INC.
$21
CTI BioPharma Corp.
$21
GE HealthCare
$19
Deciphera Pharmaceuticals Inc.
$17
Agios Pharmaceuticals, Inc.
$17
TAIHO ONCOLOGY, INC.
$17
Taiho Oncology, Inc.
$16
Sobi, Inc
$16
INSYS Therapeutics Inc
$15
Clovis Oncology, Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$14
R-Pharm US LLC
$14
Pharmacosmos Therapeutics Inc.
$13
Verastem, Inc.
$13
Teva Pharmaceuticals USA, Inc.
$12
Kyowa Kirin, Inc.
$12
NanoString Technologies, Inc.
$12
Janssen Pharmaceuticals, Inc
$12
Karyopharm Therapeutics Inc.
$11
Top 3 companies account for 26.1% of total payments
Associated products mentioned in payments ›
ALIMTA · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · FARESTON · FASENRA · FERAHEME · FRUZAQLA · Fabhalta · GAZYVA · HYQVIA · IBRANCE · IMBRUVICA · IMFINZI · IMLYGIC · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · Ixempra · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMIZYME · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tarceva · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZOLADEX · ZYKADIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
16
Per 100K population
3.6
County median income
$80,633
Nearest hospital
HCA FLORIDA ENGLEWOOD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Jacob is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and low-engagement industry engagement, with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Jacob experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Jacob performed 108,630 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jacob receive payments from pharmaceutical companies?
Yes. Dr. Jacob received a total of $13,837 from 81 companies across 695 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jacob's costs compare to other hematologys in Englewood?
Dr. Jacob's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jacob) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Englewood
Browse hematologys in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Epizyme, Inc., Payments to Doctors
See all physicians who received payments from Epizyme, Inc.,.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology